# What This Resolution Actually Does

This is a resolution condemning the Biden administration's policies on medication abortion—specifically the drug mifepristone (commonly known as RU-486). It's important to understand that this is not a law that changes anything; it's a statement of disapproval from House members. However, it lays out arguments that supporters want to use in future policy debates.

The resolution focuses on how the FDA has loosened safety requirements around mifepristone over the past two decades. Originally, when the drug was approved in 2000, it came with strict rules: women had to visit a doctor three times in person, the drug could only be used up to seven weeks of pregnancy, and doctors had to report complications. In 2016 and again in 2021, the FDA relaxed these requirements. Now, women can receive the drug by mail without ever seeing a doctor in person, it can be used up to ten weeks of pregnancy, and non-physicians can prescribe it. The resolution argues these changes prioritize access over safety.

The resolution raises specific health concerns, claiming that roughly one in twenty-five women end up in the emergency room after taking these drugs, and that removing in-person visits prevents doctors from diagnosing dangerous conditions like ectopic pregnancies (where the embryo implants outside the uterus). It also argues that mail delivery without in-person screening makes it easier for domestic abusers or traffickers to coerce women into taking the drug without their knowledge. The resolution concludes by condemning what it calls the Biden administration's "pro-abortion policies," though it doesn't propose any new laws or changes—it's essentially a formal statement of opposition to current FDA regulations.

Condemning the pro-abortion policies of the Biden administration.

Moran, Nathaniel

<p>This resolution condemns the Food and Drug Administration's decision in January 2023 to remove in-person dispensing requirements for mifepristone.</p>